Dr.Reddy's Laboratories Ltd (NYSE:RDY)

42.15
Data as of Apr 17
 0.00 / 0.00%
Today’s Change
31.32
Today|||52-Week Range
47.93
+2.73%
Year-to-Date

Stock Price Forecast

The 41 analysts offering 12-month price forecasts for Dr.Reddy's Laboratories Ltd have a median target of 50.30, with a high estimate of 66.07 and a low estimate of 41.85. The median estimate represents a +19.34% increase from the last price of 42.15.

Analyst Recommendations

The current consensus among 40 polled investment analysts is to Buy stock in Dr.Reddy's Laboratories Ltd. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.54
Sales
$587.9M
Reporting Date
May 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.57%
 
 
 
 
 
 
Growthannually 15.47%
 
 
 
 
 
 

Sales

Growthquarterly 2.90%
 
 
 
 
 
 
Growthannually 2.53%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.